COPENHAGEN (Reuters) - Danish Novo Nordisk, the world's biggest insulin producer, said on Friday it had received a product label update for diabetes drug Victoza to include data showing superior efficacy when compared with rival drug Januvia from Merck.
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/N7MZX1ts_LU/us-novonordisk-idUSBRE8350IQ20120406
auto insurance pasadena ca santa monica water damage setting up airport network
No comments:
Post a Comment